[go: up one dir, main page]

SV2010003744A - Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina - Google Patents

Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina

Info

Publication number
SV2010003744A
SV2010003744A SV2010003744A SV2010003744A SV2010003744A SV 2010003744 A SV2010003744 A SV 2010003744A SV 2010003744 A SV2010003744 A SV 2010003744A SV 2010003744 A SV2010003744 A SV 2010003744A SV 2010003744 A SV2010003744 A SV 2010003744A
Authority
SV
El Salvador
Prior art keywords
cyclodextrine
vitamin
pharmaceutical composition
strontium salt
strontium
Prior art date
Application number
SV2010003744A
Other languages
English (en)
Inventor
Gilles Briault
Xavier Quenault
Cecile Poirier
Hernandez Maria Cristina Perez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41719206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2010003744(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of SV2010003744A publication Critical patent/SV2010003744A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE UNA SAL DE ESTRONCIO, VITAMINA D Y UNA CICLODEXTRINA
SV2010003744A 2009-11-27 2010-11-24 Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina SV2010003744A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0905706A FR2953139B1 (fr) 2009-11-27 2009-11-27 Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine

Publications (1)

Publication Number Publication Date
SV2010003744A true SV2010003744A (es) 2011-03-15

Family

ID=41719206

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2010003744A SV2010003744A (es) 2009-11-27 2010-11-24 Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina

Country Status (31)

Country Link
US (1) US20110130370A1 (es)
EP (1) EP2335704A1 (es)
JP (1) JP2011111458A (es)
KR (1) KR101278935B1 (es)
CN (1) CN102078620A (es)
AP (1) AP2010005490A0 (es)
AR (1) AR079160A1 (es)
AU (1) AU2010241527B2 (es)
BR (1) BRPI1004685A2 (es)
CA (1) CA2723119C (es)
CL (1) CL2010001260A1 (es)
CO (1) CO6280058A1 (es)
CU (1) CU20100230A7 (es)
EA (1) EA018460B1 (es)
EC (1) ECSP10010622A (es)
FR (1) FR2953139B1 (es)
GE (1) GEP20135734B (es)
HN (1) HN2010002518A (es)
IL (1) IL209348A0 (es)
MA (1) MA32363B1 (es)
MX (1) MX2010012566A (es)
MY (1) MY158261A (es)
NZ (1) NZ589513A (es)
PE (1) PE20110407A1 (es)
SG (1) SG171542A1 (es)
SV (1) SV2010003744A (es)
TW (1) TW201200136A (es)
UA (1) UA105766C2 (es)
UY (1) UY33039A (es)
WO (1) WO2011064474A1 (es)
ZA (1) ZA201008230B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056937T2 (hu) 2006-02-03 2022-04-28 Opko Renal Llc A D-vitamin elégtelenség és hiány kezelése 25-hidroxivitamin D2-vel és 25-hidroxivitamin D3-mal
LT2679228T (lt) 2006-06-21 2018-05-10 Opko Ireland Global Holdings, Ltd. Terapija naudojant vitamino d atstatymo agentą ir vitamino d hormoninį pakaitinį agentą
ES2401205T3 (es) 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
BR112012012947B8 (pt) 2009-11-27 2021-05-25 Genzyme Corp sal de hemitartarato e composição farmacêutica compreendendo o mesmo
EP3636280B1 (en) 2010-03-29 2025-05-14 EirGen Pharma Ltd. Methods and compositions for reducing parathyroid levels
CN102525975B (zh) * 2011-12-14 2013-06-19 天津药物研究院药业有限责任公司 雷奈酸锶口腔崩解片及其制备方法
CN102626420B (zh) * 2012-04-13 2014-06-25 深圳大学 一种含有锶、钙和维生素d的混合制剂
ES2505716T3 (es) * 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CN103142623B (zh) * 2013-03-21 2014-04-16 青岛正大海尔制药有限公司 骨化三醇和雷尼酸锶的混悬颗粒及其制备方法
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
JP6706799B2 (ja) 2014-12-19 2020-06-10 国立大学法人 長崎大学 新規ビスホスホン酸誘導体及びその用途
SG10201913863TA (en) 2016-03-28 2020-03-30 Opko Ireland Global Holdings Limited Methods of vitamin d treatment
WO2018084959A2 (en) * 2016-09-30 2018-05-11 Nelson Deanna J Pharmaceutical quality strontium l-lactate
SG10202107237SA (en) * 2017-04-25 2021-08-30 Buck Inst Res Aging Formulations for extending lifespan and healthspan
WO2019004984A2 (en) * 2017-05-29 2019-01-03 Biofarma Ilac Sanayi Ve Ticaret A.S. PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL
CN109276710A (zh) * 2018-11-23 2019-01-29 中国医学科学院药用植物研究所海南分所 一种增加骨密度的组合物及其制备方法和用途
CN112370429A (zh) * 2019-10-21 2021-02-19 广州富诺营养科技有限公司 一种直压型有机钙维生素d3咀嚼片及其制备方法
CN114452259A (zh) * 2021-07-28 2022-05-10 安徽旺盛添加剂有限公司 一种维生素d微囊钙片及其制备方法
CN119055788A (zh) * 2023-05-31 2024-12-03 葛兰素史克消费保健（美国）控股有限责任公司 活性成分络合物及其制备方法
WO2024246793A1 (en) * 2023-05-31 2024-12-05 Haleon Us Holdings Llc Active ingredient complex and method of making thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52130904A (en) * 1976-04-26 1977-11-02 Teijin Ltd Stabilization of vitamin d#
HU177586B (en) * 1978-12-19 1981-11-28 Chinoin Gyogyszer Es Vegyeszet New process for preparing stable inclusion complexes of vitamine d with cyclodextrin
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2651497B1 (fr) 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
CN1110275A (zh) * 1994-04-06 1995-10-18 福建省药品检验所 一种维生素D与羟丙基-β-环糊精的包合物
FR2749759B1 (fr) 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
ATE348116T1 (de) * 1999-11-12 2007-01-15 Freres Roquette Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen
JP2003518515A (ja) * 1999-12-23 2003-06-10 セレスター ホールディング ベー ヴェー 安定化シクロデキストリン複合体
JP2003268005A (ja) * 2002-03-14 2003-09-25 Medorekkusu:Kk 包接体の製造法
EP2266584B1 (en) * 2003-05-07 2012-09-05 Osteologix A/S Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions
WO2004098619A2 (en) 2003-05-07 2004-11-18 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
EP1622629B1 (en) * 2003-05-07 2013-07-10 Osteologix A/S Controlled-release composition containing a strontium salt
CN100374632C (zh) * 2003-05-30 2008-03-12 三井化学株式会社 人造毛发用纤维
KR20060105735A (ko) * 2003-07-04 2006-10-11 니코메드 덴마크 에이피에스 경구용 부갑상선 호르몬 함유 약학 조성물
WO2005123130A2 (en) * 2004-06-17 2005-12-29 Osteologix A/S Improved treatments of rheumatic and arthritic diseases comprising combinations of a 5-lipoxygenase inhibitor
CA2571449C (en) * 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprising strontium and vitamin d and uses thereof
CN101018586B (zh) * 2004-06-25 2014-08-27 莫克瓦洛Spf有限公司 含锶和维生素d的组合物及其用途
WO2006105196A2 (en) * 2005-03-28 2006-10-05 Bioresponse, L.L.C. Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
DE102005017775A1 (de) * 2005-04-13 2006-10-19 Schering Ag Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins
US20070218111A1 (en) * 2006-03-16 2007-09-20 Western Holdings, Llc Strontium compositions for bones
CN1823764A (zh) * 2006-03-27 2006-08-30 重庆医药工业研究院有限责任公司 一种含有雷奈酸锶和维生素d药物组合物
FR2899895B1 (fr) 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제

Also Published As

Publication number Publication date
KR20110059546A (ko) 2011-06-02
US20110130370A1 (en) 2011-06-02
UA105766C2 (uk) 2014-06-25
FR2953139B1 (fr) 2012-04-13
NZ589513A (en) 2012-06-29
CA2723119C (fr) 2013-08-06
TW201200136A (en) 2012-01-01
MA32363B1 (fr) 2011-06-01
AU2010241527A1 (en) 2011-06-16
JP2011111458A (ja) 2011-06-09
CA2723119A1 (fr) 2011-05-27
EA201001710A2 (ru) 2011-06-30
ZA201008230B (en) 2011-07-27
FR2953139A1 (fr) 2011-06-03
AR079160A1 (es) 2011-12-28
BRPI1004685A2 (pt) 2013-03-05
AP2010005490A0 (en) 2010-12-31
CU20100230A7 (es) 2012-06-29
UY33039A (es) 2011-04-29
HN2010002518A (es) 2012-09-03
CL2010001260A1 (es) 2012-02-17
EP2335704A1 (fr) 2011-06-22
IL209348A0 (en) 2011-02-28
PE20110407A1 (es) 2011-07-02
EA201001710A3 (ru) 2011-08-30
CO6280058A1 (es) 2011-05-20
CN102078620A (zh) 2011-06-01
KR101278935B1 (ko) 2013-06-28
SG171542A1 (en) 2011-06-29
EA018460B1 (ru) 2013-08-30
WO2011064474A1 (fr) 2011-06-03
ECSP10010622A (es) 2011-06-30
MY158261A (en) 2016-09-30
GEP20135734B (en) 2013-01-25
AU2010241527B2 (en) 2013-12-19
MX2010012566A (es) 2011-05-26

Similar Documents

Publication Publication Date Title
SV2010003744A (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
IL225238B (en) Pharmaceutical composition comprising carbetocin and antioxidant
BRPI1010768A2 (pt) composto, e, composição farmacêutica.
CR20130406A (es) Composiciones farmacéuticas que comprenden anticuerpos humanos frente a pcsk9
CO6900149A2 (es) Una composición farmacéutica que comprende los fitocanabinoides canabidivarina (cbdv) y canabidiol (cbd)
HRP20160807T1 (hr) Visoko koncentrirane farmaceutske formulacije koje sadrže protutijelo anti-cd20
PH12012500948A1 (en) Oral compositions containing extracts of garcinia mangostana l. and related methods
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
HUE040119T2 (hu) Orálisan alkalmazott kortikoszteroid készítmények
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
CL2011000481S1 (es) Aplicador para cuidado oral.
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
CL2010000243S1 (es) Pilar para un implante dental
WO2012009723A8 (en) C-met modulator pharmaceutical compositions
BR112014009889A2 (pt) compostos dissubstituídos, compostos e composição farmacêutica
BRPI1009757A2 (pt) composto, composição farmacêutica, e , uso de um composto.
EP3067395A4 (en) Ultraviolet radiation-curable composition, and recorded matter
BRPI1014125A2 (pt) composto, composição farmacêutica, e, uso de um composto.
CU24163B1 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
CL2009001973S1 (es) Mostrador.
DK2389166T3 (da) Farmaceutisk sammensætning omfattende aleglitazar
HUE059408T2 (hu) Természetes gyógyászati vegyület
TR200903176A1 (tr) Çoklu blister.
BR112014016122A2 (pt) composto, e, composição farmacêutica
EP2488175A4 (en) PHARMACEUTICAL COMPOSITIONS